3KY9.B | VAV1

General Structure Information 3ky9 VAV1 autoinhibited vav1 2.73Å AUTH B.YU,I.R.MARTINS,P.LI,G.K.AMARASINGHE,J.UMETANI,AUTH 2 M.E.FERNANDEZ-ZAPICO,D.D.BILLADEAU,M.MACHIUS,D.R.TOMCHICK,AUTH 3 M.K.ROSENTITL STRUCTURAL AND ENERGETIC MECHANISMS OF COOPERATIVETITL 2 AUTOINHIBITION AND ACTIVATION OF VAV1REF CELL(CAMBRIDGE,MASS.) V. 140 246 2010REFN ISSN 0092-8674PMID 20141838DOI 10.1016/J.CELL.2009.12.033 Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic Proximity Analysis Mapped Variants

See Details
2ROR.A | VAV1

General Structure Information 2ror VAV1 solution structure of the vav1 sh2 domain complexed with a tyrosine-phosphorylated peptide from slp76 -1.0Å AUTH T.KASAI,M.TANAKA,S.KOSHIBA,T.KIGAWA,S.YOKOYAMATITL SOLUTION STRUCTURE OF THE VAV1 SH2 DOMAINTITL 2 COMPLEXED WITH A TYROSINE-PHOSPHORYLATED PEPTIDETITL 3 FROM SLP76REF TO BE PUBLISHEDREFN Variant Set Distributions Mapped Variants

See Details
1NTY.A | TRIO

General Structure Information 1nty TRIO crystal structure of the first dh/ph domain of trio to 1.7 a 1.7Å AUTH K.R.SKOWRONEK,F.GUO,Y.ZHENG,N.NASSARTITL THE C-TERMINAL BASIC TAIL OF RHOG ASSISTS THE GUANINETITL 2 NUCLEOTIDE EXCHANGE FACTOR TRIO IN BINDING TO PHOSPHOLIPIDS.REF J.BIOL.CHEM. V. 279 37895 2004REFN ISSN 0021-9258PMID 15199069DOI 10.1074/JBC.M312677200 Variant Set Distributions Mapped Variants

See Details